SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provided a business update and announced financial results for the third quarter ended

GOTHENBURG, Nov. 13, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that the board of Isofol has decided that from today's date, November 13 2019, appoint the chairman of the board, Dr Jarl Ulf Jungnelius, M.D., as CEO of the company. Consequently, Ulf Jungnelius steps down from his po

STOCKHOLM, Nov. 13, 2019 /PRNewswire/ -- Bioservo has finished a successful long term trial with Ironhand® at Toyota Motor North America plants in Kentucky and West Virginia.Since April, Bioservo and Toyota has conducted a joint pilot project at the Kentucky

LINKÖPING, Sweden and ALMERE, the Netherlands, Nov. 13, 2019  /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra&

WATERTOWN, Mass., Nov. 13, 2019 /PRNewswire/ -- Arranta Bio ("Arranta") announced today the acquisition of Captozyme™, and with it the establishment of Arranta's Center of Excellence for process and analytical development and early clinical supply for microbiome clients with the transfer of the Captozyme team and facilities in

OSLO, Norway, Nov. 13, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the third quarter 2019 on Tuesday, 19 November 2019. A presentation by Nordic Nanovector's senior management team will take place at 8:30am CET at:Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 OsloM

NORTH CHICAGO, Ill., Nov. 12, 2019 /PRNewswire/ -- AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today that it has priced its previously announced private offering (the "Offering") of senior unsecured notes in a combined aggregate principal amount of $30 billion (collectively, the "Notes"). The Notes will be issued in ten tranches: (i) $75

COLUMBUS, Ga., Nov. 12, 2019 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that Frederick J. Crawford, who currently serves as executive vice president and chief financial officer, will be promoted to president and chief operating officer of Aflac Incorporated, continuing to report to Aflac Incorporated Chairman and Ch

MELBOURNE, Australia, Nov. 12, 2019 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, has been issued patent #320872 from the Government of India Patent Office for the Company's core intellectual property related to detection, measurement and imaging using targeted magnetic nan

BUFFALO, N.Y., Nov. 12, 2019 /PRNewswire/ -- A New York State court granted a temporary restraining order today, re-admitting disabled student Ameer Hamideh to school at the CHC Learning Center here, according to Informed Consent Action Network (ICAN) which supported Ameer's case.Nine-year old Ameer became an unwilling national sto